Viewing nowPregalin Capsule 25 mg (Pregabalin)
Pregabalin 25mg
Hard capsule · Prescription medication
Korea United Pharm, Co., Ltd.

MFDS item code 201802254 · Approved 2018.05.30 · Insurance code 642803100
Pain relief for peripheral and central neuropathic pain and fibromyalgia, adjunctive treatment for partial seizures in epilepsy.
This medication helps relieve peripheral and central neuropathic pain in adults. It is also used as an adjunctive treatment for partial seizures in patients with epilepsy. Additionally, it is effective in relieving pain due to fibromyalgia. Aiming to improve the quality of life of patients with these various symptoms.
This medication is taken orally, divided into two doses daily regardless of food intake. 1. Neuropathic pain 1) Peripheral neuropathic pain: The starting dose is 150 mg per day, which can be increased to 300 mg per day after 3 to 7 days. If needed, doses may be increased up to a maximum of 600 mg per day in increments of 7 days. 2) Central neuropathic pain: The starting dose is 150 mg per day.
The safety and efficacy data for children under 12 years and adolescents aged 12-17 are insufficient, so use is not recommended.
This medication may increase the risk of suicidal thoughts or behaviors; if depression or mood changes occur during use, inform your healthcare provider immediately. Do not take this medication if you have an allergy to it or have genetic issues like lactose intolerance. Diabetic patients should be cautious as this medication may lead to weight gain, necessitating adjustments in doses of blood glucose controlling medications. If you experience a severe allergic reaction such as angioedema, discontinue use immediately and consult your healthcare provider. Elderly patients should be careful during initial use, as this medication may cause increased dizziness or drowsiness. Visual disturbances or changes may occur during use, which can improve once the medication is stopped. There is insufficient data to make a safe decision about discontinuing other antiepileptic drugs when using this medication as a standalone treatment. Sudden discontinuation of this medication may result in withdrawal symptoms such as insomnia, headaches, and anxiety; it is advisable to taper off gradually in consultation with your healthcare provider. Patients with a history of substance abuse may be at a higher risk of abuse with this medication, so caution is advised when taking it. Patients with compromised renal function may require dosage adjustments for this medication. Patients with heart disease should be careful as there have been reports of congestive heart failure risk associated with this medication. Combining this medication with opioid analgesics may increase the risk of central nervous system depression; special caution is required when used together. Patients with respiratory or neurologic diseases or the elderly may be at a higher risk of severe respiratory depression and may need dosage adjustments. Pregnant women should avoid this medication due to the risk of fetal malformations, and women of childbearing potential should use effective contraception. Breastfeeding women should consult their healthcare provider, as this medication can be transmitted through breast milk, and may need to discontinue breastfeeding or the medication. Caution should be taken during dangerous activities such as driving or operating machinery, as dizziness or drowsiness may occur after taking this medication. If symptoms such as rash, fever, or swelling around the lips or eyes occur while taking this medication, discontinue use immediately and inform your healthcare provider. In case of an overdose, symptoms may include drowsiness, confusion, depression, seizures, and immediate treatment at a hospital is required. This medication must be kept out of the reach of children and should not be transferred to other containers.
Hives, severe swelling (edema), angioedema, facial swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/conjunctival mucosal pain, Stevens-Johnson syndrome, toxic epidermal necrolysis, pulmonary edema, mucocutaneous syndrome, anaphylaxis-like symptoms, shock, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, jaundice of the skin or eyes.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, in a cool place between 15 to 30 degrees Celsius. Proper storage ensures the medication retains its effectiveness.
A hard capsule with a colorless or pale yellow body and white powder inside.
30 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 25mg
Hard capsule · Prescription medication
Korea United Pharm, Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.